Cargando…

AB053. Labeling of prostate tumor-specific replication-selective oncolytic adenoviruses with radioactive 125I: inhibitory effects on prostate cancer cell

BACKGROUND: The authors established a 125I-labeled replication-selective oncolytic adenovirus and human telomerase reverse transcriptase/prostate-specific antigen (125I-RSOAds-hTERT/PSA) oncolytic adenovirus marker and investigated the effects of different labeling conditions. This study also explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Lin, Han, Conghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Printed Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565601/ http://dx.doi.org/10.21037/tau.2017.s053

Ejemplares similares

AB125. The correlation of SRSF1 and survivin in prostate cancer
por: Xiao, Bangming, et al.
Publicado: (2016)

Stability analysis on the radioactive iodine-labelled prostate cancer-specific recombinant oncolytic adenovirus
por: Zhou, Jiahe, et al.
Publicado: (2017)

AB133. Xanthogranulomatous prostatitis with benign prostatic hyperplasia: a case report and review of the literature
por: Wang, Anxi
Publicado: (2016)

AB077. The expression and clinical significance of α-actinin-1 in prostate cancer and benign prostatic hyperplasia
por: Cao, Feng-Hong
Publicado: (2017)

AB067. Transurethral endoscopic treatment of benign prostatic hyperplasia
por: Meng, Qingjun, et al.
Publicado: (2017)

AB263. Ideas from study on pathological large slices of prostate
por: Qu, Yanchun, et al.
Publicado: (2016)

AB060. Long-term outcome following thulium vaporesection of the prostate
por: Zhang, Zhaocun, et al.
Publicado: (2017)

AB142. Normal peripheral prostate stromal cells stimulate prostate cancer development: roles of c-kit signal
por: Gao, Jianhua
Publicado: (2016)

AB205. Open prostatectomy vs. laparoscopic prostatectomy for benign prostatic hyperplasia with large volume prostate: a meta-analysis
por: Chen, H, et al.
Publicado: (2016)

AB262. Expression of vasohibin-1 in prostate cancer and its progress research
por: Zhang, Bo, et al.
Publicado: (2016)

AB177. Clinical and pathological research of prostate cancer with Gleason score 10
por: Yan, Bin, et al.
Publicado: (2016)

AB056. Cytoreductive radical prostatectomy for men with oligo-metastatic prostate cancer
por: Liu, Shengjie, et al.
Publicado: (2017)

AB065. EP4 antagonist suppresses bone metastasis in prostate cancer
por: Xu, Song, et al.
Publicado: (2017)

AB158. Atorvastatin induces autophagic cell death in prostate cancer cells in vitro
por: He, Zhenhua, et al.
Publicado: (2016)

AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2016)

AB076. High expression of FTL protein in prostate cancer and its clinical significance
por: Cao, Feng-Hong
Publicado: (2017)

AB070. Roles and mechanisms of soybean isoflavones in androgen-independent transformation of prostate cancer
por: Xu, Li, et al.
Publicado: (2017)

AB123. Gonorrhea and prostate cancer incidence: an updated meta-analysis of 21 epidemiologic studies
por: Zhao, Shanchao, et al.
Publicado: (2016)

AB223. A novel surgical management for male infertility secondary to midline prostatic cyst
por: Cheng, Gong, et al.
Publicado: (2016)

AB078. Knockdown of SPC25 inhibits cell proliferation and cycle progression in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017)

AB066. MiR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
por: Xu, Song, et al.
Publicado: (2017)

AB190. Could magnetic resonance imaging help identify the presence of prostate cancer before initial biopsy? The development of nomogram predicting the outcomes of prostate biopsy in the Chinese population
por: Fang, Dong, et al.
Publicado: (2016)

AB052. ZEB1 promotes vasculogenic mimicry formation in prostate cancer is associated with epithelial-mesenchymal transition
por: Wang, Hua, et al.
Publicado: (2017)

AB189. Prevalence and risk factors of prostate cancer in Chinese men with PSA 4–10 ng/mL underwent TRUS-guided prostate biopsy: the utilization of PAMD score
por: Fang, Dong, et al.
Publicado: (2016)

AB124. Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer
por: Zhao, Shancho, et al.
Publicado: (2016)

AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017)

AB067. Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy (RALP) for oligometastatic prostate cancer versus non-oligometastatic prostate cancer: a propensity score matching study
por: Qu, Min, et al.
Publicado: (2018)

AB061. Are post-operative irritative symptoms more favorable in GreenLight XPS 180W laser vaporization of the prostate compared to GreenLight KTP 80W laser vaporization of the prostate?
por: Ahn, Sun Tae, et al.
Publicado: (2017)

AB064. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer
por: Xu, Song, et al.
Publicado: (2017)

AB219. Comparison of National Institutes of Health-Chronic Prostatitis Symptom Index with International Index of Erectile Function-5 in men with chronic prostatitis/chronic pelvic pain syndrome: a large cross-sectional study in China
por: Gao, Jingjing, et al.
Publicado: (2016)

AB064. The efficacy of UroLift in Korean men with benign prostatic hyperplasia: preserving sexual function and improving lower urinary tract symptoms
por: Tae, Sun, et al.
Publicado: (2018)

AB140. Efficacy of radical prostatectomy combined with neoadjuvant chemotherapy in the treatment of locally advanced prostate cancer: preliminary experiences from a single center
por: Xue, Wei, et al.
Publicado: (2016)

AB170. Quercetin inhibits angiogenesis through thrombospondin-1 up-regulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo
por: Yang, Feiya, et al.
Publicado: (2016)

AB226. The relationship between self-estimated intravaginal ejaculatory latency time and International Prostate Symptom Score in middle-aged men complaining of ejaculating prematurely in China
por: Zhang, X, et al.
Publicado: (2016)

AB058. Therapeutic efficacy of trans-rectal triple physiotherapy combined with pharmacotherapy in comparison with pharmacotherapy alone in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
por: Cheng, Shanshan, et al.
Publicado: (2017)

AB220. Relationships between intravaginal ejaculatory latency time and National Institutes of Health-Chronic Prostatitis Symptom Index in the four types of premature ejaculation syndromes: a large observational study in China
por: Gao, Jingjing, et al.
Publicado: (2016)

AB078. Does the interval from prostate biopsy to robot-assisted laparoscopic radical prostatectomy (RALP) influence the difficulty of the operation? —a retrospective single-surgeon analysis based on segmented operative time
por: Chen, Rui, et al.
Publicado: (2018)

AB080. Relationships between intravaginal ejaculatory latency time and National Institutes of Health-Chronic Prostatitis Symptom Index in the four types of premature ejaculation syndromes: a large observational study in China
por: Gao, Jingjing, et al.
Publicado: (2018)

AB063. A prostaglandin E (PGE) receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP-PKA/PI3K-AKT signaling pathway
por: Xu, Song, et al.
Publicado: (2017)

AB193. Rectourethral fistula
por: Jiang, Hai
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8qivccb62jvd49b99bskd4r0r7